Answers are grounded in this paper and cite their sources.
Aim: To test the hypothesis that lipocalin-type prostaglandin D synthase (L-PGDS), a marker of vascular endothelial cell disorders, may be a diagnostic for preeclampsia.Methods: Plasma and urine were collected from 36 preeclamptic patients and 94 normal pregnant women. L-PGDS concentrations were determined by sandwich ELISA assay. Receiver operating characteristic (ROC) curve validated the cut-off point of the assay.Results: The plasma and urinary L-PGDS concentrations were significantly higher in the preeclamptic patients than the normal pregnant women. Urinary L-PGDS concentrations of the normal pregnant women were higher in the third trimester compared to earlier pregnancy, while plasma concentrations remained unchanged. Urinary L-PGDS levels were significantly higher in early onset of preeclampsia (onset <32 weeks gestation) compared with late onset and in the severe compared to mild preeclampsia. ROC curve showed the cut-off point of 58.85 μg/dl (sensitivity 76.5%, specificity 75.6%, positive predictive value [PPV] 46.4%, negative predictive value [NPV] 92.1% and area under the curve [AUC] 0.82) in the plasma and 2.195 μg/dl (sensitivity 84.6%, specificity 58.7%, PPV 33.8%, NPV 93.8% and AUC 0.76) in urine.Conclusions: Our results indicate that plasma and urinary concentrations of L-PGDS may be a potential diagnostic for preeclampsia.
No takes yet. Share an insight, caveat, or question.
Kinoshita et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: